Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Hinchcliff

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Gynecologic Oncology|December 4, 2013
The value of re-exploration in patients with inadvertently morcellated uterine sarcomaTitilope Oduyebo, Alejandro J Rauh-Hain, Emily E Meserve, et al.
Journal of Minimally Invasive Gynecology|August 9, 2015
Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic SurgeryTitilope Oduyebo, Emily Hinchcliff, Emily E Meserve, et al.
Case Reports in Oncology|May 1, 2023
Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case ReportSamantha Batman, J Alejandro Rauh-Hain, Michaela Onstad Grinsfelder, et al.
Gynecologic Oncology|July 5, 2025
Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancerJason N Silberman, Annella Benjamin, Payton Solk, et al.
Med (New York, N.Y.)|March 12, 2024
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosisAnne Knisely, Emily Hinchcliff, Bryan Fellman, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Gynecologic Oncology|December 4, 2013
The value of re-exploration in patients with inadvertently morcellated uterine sarcomaTitilope Oduyebo, Alejandro J Rauh-Hain, Emily E Meserve, et al.
Journal of Minimally Invasive Gynecology|August 9, 2015
Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic SurgeryTitilope Oduyebo, Emily Hinchcliff, Emily E Meserve, et al.
Case Reports in Oncology|May 1, 2023
Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemorefractory Endometrial Carcinoma in a Patient with Lynch Syndrome: A Case ReportSamantha Batman, J Alejandro Rauh-Hain, Michaela Onstad Grinsfelder, et al.
Gynecologic Oncology|July 5, 2025
Fit4Surgery: A pilot randomized controlled trial to assess the feasibility of prehabilitation prior to debulking surgery for ovarian cancerJason N Silberman, Annella Benjamin, Payton Solk, et al.
Med (New York, N.Y.)|March 12, 2024
Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosisAnne Knisely, Emily Hinchcliff, Bryan Fellman, et al.
Pageof 4